Banque Transatlantique SA Acquires Shares of 128,285 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Banque Transatlantique SA purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 128,285 shares of the medical equipment provider's stock, valued at approximately $66,958,000. Intuitive Surgical makes up 1.6% of Banque Transatlantique SA's investment portfolio, making the stock its 17th largest holding.

Other institutional investors also recently bought and sold shares of the company. Atala Financial Inc purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $25,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the 4th quarter valued at about $26,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. CICC Research assumed coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. Evercore ISI lowered their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, Royal Bank of Canada dropped their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,313 shares of company stock valued at $17,229,143 in the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock traded down $0.83 during mid-day trading on Friday, hitting $537.33. The company had a trading volume of 601,303 shares, compared to its average volume of 1,624,406. The company has a market capitalization of $192.59 billion, a P/E ratio of 83.83, a P/E/G ratio of 5.85 and a beta of 1.70. The stock's 50 day moving average price is $501.36 and its 200-day moving average price is $534.58. Intuitive Surgical, Inc. has a 52-week low of $379.67 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.